# Zentek Ltd.: overview ZTEKF · OTC · CIK 1904501 · [Materials](/sectors/materials.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/ztekf.md) · [Financials](/companies/ztekf/financials.md) · [Filings](/companies/ztekf/filings.md) · [Insiders](/companies/ztekf/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001062993-22-021579.md) | [0.3](/filings/0001062993-23-014199.md) | [0.1](/filings/0001062993-23-014199.md) | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(183172.8%)](/filings/0001062993-22-021579.md) | [(3618.5%)](/filings/0001062993-23-014199.md) | [(20550.1%)](/filings/0001062993-24-013081.md) | not reported | not reported | | Net margin | % | [(164273.9%)](/filings/0001062993-22-021579.md) | [(9128.9%)](/filings/0001062993-23-014199.md) | [(19784.9%)](/filings/0001062993-24-013081.md) | not reported | not reported | | Diluted EPS | $ per share | [0.05](/filings/0001062993-22-021579.md) | [(0.34)](/filings/0001062993-23-014199.md) | [(0.14)](/filings/0001062993-24-013081.md) | [(0.12)](/filings/0001062993-25-012177.md) | [(0.10)](/filings/0001062993-25-012177.md) | | Free cash flow | $m | [(2.0)](/filings/0001062993-22-021579.md) | [(12.0)](/filings/0001062993-23-014199.md) | [(15.2)](/filings/0001062993-24-013081.md) | [(8.4)](/filings/0001062993-25-012177.md) | [(6.3)](/filings/0001062993-25-012177.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue; Gross profit: ifrs-full:GrossProfit. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ztekf/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Cable Car Capital, LP](/funds/1699575.md) | 2026-06-30 | $774.7k | 1,692,000 | | New +1,692,000 | | [SCOTIA CAPITAL INC.](/funds/1335644.md) | 2026-06-30 | $194.4k | 424,216 | | Reduced −421,449 | | [Periscope Capital Inc.](/funds/1695320.md) | 2026-06-30 | $183.2k | 400,000 | | New +400,000 | | [TD Waterhouse Canada Inc.](/funds/1999606.md) | 2026-06-30 | $133.1k | 281,680 | | Added +252,500 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $133.0k | 285,459 | | Added +23,785 | | [SIGNATUREFD, LLC](/funds/1456048.md) | 2026-06-30 | $58.5k | 125,000 | | Unchanged | | [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $47.6k | 103,884 | | Added +14,000 | | [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $44.4k | 96,893 | | Added +36,000 | | [BCV Asset Management Inc.](/funds/2110721.md) | 2026-06-30 | $33.3k | 70,600 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $32.4k | 69,223 | | Added +15,369 | ## Recent filings [All 205 filings](/companies/ztekf/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 12:34 ET | [6-K](/filings/0001062993-26-005544.md) | Report of a foreign private issuer, period 2026-10-26 | 0001062993-26-005544 | | 2026-10-07 | 09:41 ET | [6-K](/filings/0001062993-26-005221.md) | Report of a foreign private issuer, period 2026-10-05 | 0001062993-26-005221 | | 2026-10-05 | 14:08 ET | [6-K](/filings/0001062993-26-005178.md) | Report of a foreign private issuer, period 2026-10-05 | 0001062993-26-005178 | | 2026-10-01 | 10:03 ET | [6-K](/filings/0001062993-26-005131.md) | Report of a foreign private issuer, period 2026-10-01 | 0001062993-26-005131 | | 2026-09-24 | 08:03 ET | [6-K](/filings/0001437749-26-031107.md) | Report of a foreign private issuer, period 2026-09-30 | 0001437749-26-031107 | | 2026-09-16 | 10:10 ET | [6-K](/filings/0001062993-26-004978.md) | Report of a foreign private issuer, period 2026-09-16 | 0001062993-26-004978 | | 2026-09-14 | 14:31 ET | [6-K](/filings/0001062993-26-004919.md) | Report of a foreign private issuer, period 2026-09-14 | 0001062993-26-004919 | | 2026-09-02 | 19:44 ET | [6-K](/filings/0001062993-26-004778.md) | Report of a foreign private issuer, period 2026-09-01 | 0001062993-26-004778 | | 2026-08-31 | 11:01 ET | [6-K](/filings/0001062993-26-004721.md) | Report of a foreign private issuer, period 2026-08-31 | 0001062993-26-004721 | | 2026-08-28 | 17:29 ET | [6-K](/filings/0001062993-26-004710.md) | Report of a foreign private issuer, period 2026-08-28 | 0001062993-26-004710 | ## Latest annual report [Form 40-F for the fiscal year ended Mar 31, 2026](/filings/0001062993-26-003347.md), filed Jun 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1904501 - Tickers: ZTEKF - Exchange: OTC - SIC code: 2890 Miscellaneous Chemical Products - State of incorporation: A6 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.